Literature DB >> 2006582

Retinal vasculitis.

G N Holland.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 2006582      PMCID: PMC1002728     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  28 in total

1.  Retinal vasculitis. A review of the clinical signs.

Authors:  T J Ffytche
Journal:  Trans Ophthalmol Soc U K       Date:  1977-09

2.  Atypical syphilitic chorioretinitis and vasculitis.

Authors:  C M Morgan; R M Webb; G R O'Connor
Journal:  Retina       Date:  1984 Fall-Winter       Impact factor: 4.256

3.  Syphilitic phlebitis simulating branch vein occlusion.

Authors:  L A Lobes; J C Folk
Journal:  Ann Ophthalmol       Date:  1981-07

4.  Bilateral retinal vasculitis associated with clotting disorders.

Authors:  H Savir; T Wender; D Creter; M Djaldetti; R Stein
Journal:  Am J Ophthalmol       Date:  1977-10       Impact factor: 5.258

5.  Retinal vasculitis in ocular toxoplasmosis in nonhuman primates.

Authors:  R M Webb; K F Tabbara; G R O'Connor
Journal:  Retina       Date:  1984 Summer-Fall       Impact factor: 4.256

6.  Tuberculous retinal vasculitis.

Authors:  J A Fountain; R B Werner
Journal:  Retina       Date:  1984 Winter-Spring       Impact factor: 4.256

7.  Immunological investigations in retinal vasculitis.

Authors:  E Graham; D J Spalton; M D Sanders
Journal:  Trans Ophthalmol Soc U K       Date:  1981

8.  The role of hypersensitivity reactions to toxoplasma antigens in experimental ocular toxoplasmosis in nonhuman primates.

Authors:  P E Newman; R Ghosheh; K F Tabbara; G R O'Connor; W Stern
Journal:  Am J Ophthalmol       Date:  1982-08       Impact factor: 5.258

9.  Acquired immune deficiency syndrome. Ocular manifestations.

Authors:  G N Holland; J S Pepose; T H Pettit; M S Gottlieb; R D Yee; R Y Foos
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

10.  Microvascular aspects of acquired immune deficiency syndrome retinopathy.

Authors:  D A Newsome; W R Green; E D Miller; L A Kiessling; B Morgan; D A Jabs; B F Polk
Journal:  Am J Ophthalmol       Date:  1984-11       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.